Hartford Financial Management Inc. Biogen Inc. Transaction History

Hartford Financial Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $5,715 - $7,101	30 New	30 $6,000
Q1 2023 Apr 25, 2023	SELL	$256.56 - $292.34 $8,979 - $10,231	-35 Reduced 53.03%	31 $8,000
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $11,359 - $13,802	-45 Reduced 40.54%	66 $18,000
Q3 2022 Oct 25, 2022	SELL	$194.69 - $268.46 $778 - $1,073	-4 Reduced 3.48%	111 $30,000
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $32,332 - $37,914	115	115 $36,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hartford Financial Management Inc. with notifications on news.